Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.35 USD | -0.89% | -2.79% | -16.63% |
Apr. 19 | BMO Capital Adjusts Price Target on Incyte to $56 From $64 | MT |
Apr. 01 | Incyte, China Medical System Sign Collaboration, License Agreement | MT |
Financials (USD)
Sales 2024 * | 4.13B | Sales 2025 * | 4.59B | Capitalization | 11.75B |
---|---|---|---|---|---|
Net income 2024 * | 815M | Net income 2025 * | 1.02B | EV / Sales 2024 * | 1.79 x |
Net cash position 2024 * | 4.37B | Net cash position 2025 * | 5.68B | EV / Sales 2025 * | 1.32 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
11.7
x | Employees | 2,524 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.41% |
Latest transcript on Incyte Corporation
1 day | -0.89% | ||
1 week | -2.79% | ||
Current month | -8.11% | ||
1 month | -10.25% | ||
3 months | -14.86% | ||
6 months | -5.91% | ||
Current year | -16.63% |
Managers | Title | Age | Since |
---|---|---|---|
Herve Hoppenot
CEO | Chief Executive Officer | 64 | 14-01-12 |
Director of Finance/CFO | 53 | 19-02-10 | |
Pablo Cagnoni
PSD | President | 60 | 23-06-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 00-12-31 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 19-12-15 |
Director/Board Member | 70 | 15-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.55% | 215 M€ | +13.63% | - | |
2.94% | 1 M€ | 0.00% | - | |
2.88% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 52.35 | -0.89% | 2,181,297 |
24-04-18 | 52.82 | +0.19% | 1,830,343 |
24-04-17 | 52.72 | -0.94% | 2,525,527 |
24-04-16 | 53.22 | -0.39% | 1,465,377 |
24-04-15 | 53.43 | -0.78% | 1,574,419 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.63% | 11.75B | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-11.19% | 11.69B | |
-2.25% | 8.13B | |
+1.05% | 7.55B |
- Stock Market
- Equities
- INCY Stock